Herbert Loong Highlights Advances in NSCLC at ASCOMOS 26
Herbert Loong/LinkedIn

Herbert Loong Highlights Advances in NSCLC at ASCOMOS 26

Herbert Loong, Advisor at Greater Bay Area International Clinical Trial Institute, and Steering Committee Member at Lung Cancer Policy Network, shared a post on LinkedIn:

“Many thanks to my colleagues in Malaysia for your very gracious invite for ASCOMOS 26 and your generous hospitality over the last 2 days. Had the chance to speak on Antibody Drug Conjugates and perioperative immunochemotherapy in NSCLC .

Managed to try some local delicacies including Durian and Uncle Rogers as well.”

Other articles featuring Herbert Loong on OncoDaily.